{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:55:02Z","timestamp":1764996902893},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T00:00:00Z","timestamp":1293753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11899-010-0076-4","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T01:31:15Z","timestamp":1293672675000},"page":"58-66","source":"Crossref","is-referenced-by-count":21,"title":["Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?"],"prefix":"10.1007","volume":"6","author":[{"given":"Deborah A.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Faderl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"John T.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrick","family":"Hagemeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,31]]},"reference":[{"key":"76_CR1","first-page":"181","volume-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"JE Diebold","year":"2001","unstructured":"Diebold JE, Jaffe ES, Raphael M, Warnke RA. Burkitt lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman J, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:181\u2013184"},{"key":"76_CR2","first-page":"523","volume":"2009","author":"JES The","year":"2008","unstructured":"Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. 2009:523\u2013531.","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"76_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/1097-0142(19830515)51:10<1777::AID-CNCR2820511003>3.0.CO;2-E","volume":"51","author":"DP Burkitt","year":"1983","unstructured":"Burkitt DP. The discovery of Burkitt\u2019s lymphoma. Cancer. 1983;51:1777\u20131786.","journal-title":"Cancer."},{"key":"76_CR4","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009\u20133020.","journal-title":"Blood."},{"key":"76_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol. 2006;1:375\u2013404.","journal-title":"Annu Rev Pathol."},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht JL, Aster JC. Molecular biology of Burkitt\u2019s lymphoma. J Clin Oncol. 2000;18:3707\u20133721.","journal-title":"J Clin Oncol."},{"key":"76_CR7","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/sj.leu.2403847","volume":"19","author":"T Burmeister","year":"2005","unstructured":"Burmeister T, Schwartz S, Horst HA, et al. Molecular heterogeneity of sporadic adult Burkitt-type leukemia\/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia. 2005;19:1391\u20131398.","journal-title":"Leukemia."},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1073\/pnas.85.8.2748","volume":"85","author":"A Neri","year":"1988","unstructured":"Neri A, Barriga F, Knowles DM, Magrath IT, Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci U S A. 1988;85:2748\u20132752.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"76_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","volume":"149","author":"K Klapproth","year":"2010","unstructured":"Klapproth K, Wirth T. Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol. 2010;149:484\u2013497.","journal-title":"Br J Haematol."},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","volume":"112","author":"GM Mead","year":"2008","unstructured":"\u2022 Mead GM, Barrans SL, Qian W, et al. A prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial). Blood. 2008;112:2248\u20132260. This is one of the few prospective clinicopathologic studies of aggressive, mature B-cell NHL treated uniformly with a similar risk-adapted therapeutic regimen.","journal-title":"Blood."},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","volume":"29","author":"RF McClure","year":"2005","unstructured":"McClure RF, Remstein ED, Macon WR, et al. Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior. Am J Surg Pathol. 2005;29:1652\u20131660.","journal-title":"Am J Surg Pathol."},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1080\/10428190600687547","volume":"47","author":"H Mossafa","year":"2006","unstructured":"Mossafa H, Damotte D, Jenabian A, et al. Non-Hodgkin\u2019s lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis. Leuk Lymphoma. 2006;47:1885\u20131893.","journal-title":"Leuk Lymphoma."},{"key":"76_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/10428190310001593120","volume":"45","author":"WY Au","year":"2004","unstructured":"Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma. 2004;45:519\u2013528.","journal-title":"Leuk Lymphoma."},{"key":"76_CR14","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"\u2022 Barrans S, Crouch S, Smith A, et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol. 2010;28:3360\u20133365. MYC rearrangement was determined to be an independent factor for worse survival (in conjunction with age and International Prognostic Index) for de novo DLBCL treated with CHOP-R.","journal-title":"J Clin Oncol."},{"key":"76_CR15","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"A clinical evaluation of the International Lymphoma Study","year":"1997","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89:3909\u20133918.","journal-title":"Blood"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361\u20131392.","journal-title":"Blood."},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas","year":"1982","unstructured":"National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. Cancer. 1982;49:2112\u20132135.","journal-title":"Cancer"},{"key":"76_CR18","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood.V97.12.3713","volume":"97","author":"RM Braziel","year":"2001","unstructured":"Braziel RM, Arber DA, Slovak ML, et al. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood. 2001;97:3713\u20133720.","journal-title":"Blood."},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","volume":"29","author":"E Haralambieva","year":"2005","unstructured":"Haralambieva E, Boerma EJ, van Imhoff GW, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. Am J Surg Pathol. 2005;29:1086\u20131094.","journal-title":"Am J Surg Pathol."},{"key":"76_CR20","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1200\/JCO.2008.16.4061","volume":"26","author":"AS LaCasce","year":"2008","unstructured":"\u2022 LaCasce AS, Kho ME, Friedberg JW, et al. Comparison of referring and final pathology for patients with non-Hodgkin\u2019s lymphoma in the National Comprehensive Cancer Network. J Clin Oncol. 2008;26:5107\u20135112. The overall pathological discordance rate for five B-cell NHL subtypes was 6% for 731 cases; the highest concordance rate was for DLBCL. Therapy would have been altered for 80% of the discordant cases.","journal-title":"J Clin Oncol."},{"key":"76_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1309\/7CEAWV0DNLLUWQTF","volume":"124","author":"RP Gormley","year":"2005","unstructured":"Gormley RP, Madan R, Dulau AE, et al. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases. Am J Clin Pathol. 2005;124:790\u2013798.","journal-title":"Am J Clin Pathol."},{"key":"76_CR22","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med. 2006;354:2431\u20132442.","journal-title":"N Engl J Med."},{"key":"76_CR23","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"M Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419\u20132430.","journal-title":"N Engl J Med."},{"key":"76_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2008-01-136465","volume":"112","author":"W Klapper","year":"2008","unstructured":"Klapper W, Szczepanowski M, Burkhardt B, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood. 2008;112:1374\u20131381.","journal-title":"Blood."},{"key":"76_CR25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"I Magrath","year":"1996","unstructured":"Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925\u2013934.","journal-title":"J Clin Oncol."},{"key":"76_CR26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 1996;87:495\u2013508.","journal-title":"Blood."},{"key":"76_CR27","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O\u2019Brien S, et al. Hyper-CVAD program in Burkitt\u2019s-type adult acute lymphoblastic leukemia. J Clin Oncol. 1999;17:2461\u20132470.","journal-title":"J Clin Oncol."},{"key":"76_CR28","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, Petroni GR, Schiffer CA, et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol. 2001;19:4014\u20134022.","journal-title":"J Clin Oncol."},{"key":"76_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol. 2002;13:1264\u20131274.","journal-title":"Ann Oncol."},{"key":"76_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/cncr.20143","volume":"100","author":"DA Rizzieri","year":"2004","unstructured":"Rizzieri DA, Johnson JL, Niedzwiecki D, et al. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004;100:1438\u20131448.","journal-title":"Cancer."},{"key":"76_CR31","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/1042819031000141301","volume":"45","author":"A Lacasce","year":"2004","unstructured":"Lacasce A, Howard O, Lib S, et al. Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma. 2004;45:761\u2013767.","journal-title":"Leuk Lymphoma."},{"key":"76_CR32","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/cncr.21776","volume":"106","author":"DA Thomas","year":"2006","unstructured":"Thomas DA, Faderl S, O\u2019Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569\u20131580.","journal-title":"Cancer."},{"key":"76_CR33","doi-asserted-by":"publisher","first-page":"449s","DOI":"10.1200\/JCO.2006.09.2346","volume":"25","author":"K Dunleavy","year":"2007","unstructured":"Dunleavy K, Healey Bird BR, Pittaluga S, et al. Efficacy and toxicity of dose-adjusted EPOCH-rituximab in adults with newly diagnosed Burkitt lymphoma [abstract 8035]. J Clin Oncol. 2007;25:449\u00a0s.","journal-title":"J Clin Oncol"},{"key":"76_CR34","doi-asserted-by":"crossref","first-page":"159a","DOI":"10.1182\/blood.V110.11.518.518","volume":"110","author":"D Hoelzer","year":"2007","unstructured":"Hoelzer D, Hiddemann W, Baumann A, et al. High survival rate in adult Burkitt\u2019s lymphoma\/leukemia and diffuse large B-cell lymphoma with mediastinal involvement [abstract 518]. Blood. 2007;110:159a.","journal-title":"Blood."},{"issue":"suppl 4","key":"76_CR35","first-page":"iv83","volume":"19","author":"D Hoelzer","year":"2008","unstructured":"\u2022 Hoelzer D. Recent results in the treatment of Burkitt lymphomas. Ann Oncol. 2008;19(suppl 4):iv83. Outcomes were improved with the addition of rituximab to the Berlin-Frankfurt-Munster (BFM) regimens, but there was a high incidence of central nervous system relapse in older patients with Burkitt lymphoma\/leukemia owing to reduced systemic methotrexate and omission of systemic cytarabine.","journal-title":"Ann Oncol."},{"key":"76_CR36","doi-asserted-by":"crossref","unstructured":"Abramson JS, Barnes JA, Toomey CE, et al. Rituximab added to CODOX-M\/IVAC is highly effective in HIV-negative and HIV-positive Burkitt lymphoma [abstract 3595]. Blood. 2008;112.","DOI":"10.1182\/blood.V112.11.3595.3595"},{"issue":"Suppl 3","key":"76_CR37","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.3816\/CLM.2009.s.017","volume":"9","author":"VP Kenkre","year":"2009","unstructured":"Kenkre VP, Stock W. Burkitt lymphoma\/leukemia: improving prognosis. Clin Lymphoma Myeloma. 2009;9 Suppl 3:S231\u2013238.","journal-title":"Clin Lymphoma Myeloma."},{"key":"76_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1349-7006.2007.00681.x","volume":"99","author":"Y Nomura","year":"2008","unstructured":"Nomura Y, Karube K, Suzuki R, et al. High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients. Cancer Sci. 2008;99:246\u2013252.","journal-title":"Cancer Sci."},{"key":"76_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.humpath.2009.10.027","volume":"41","author":"A Carbone","year":"2010","unstructured":"Carbone A, Gloghini A, Aiello A, Testi A, Cabras A. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology. Hum Pathol. 2010;41:621\u2013631.","journal-title":"Hum Pathol."},{"key":"76_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hon.914","volume":"27","author":"C Bellan","year":"2009","unstructured":"Bellan C, Stefano L, Giulia de F, Rogena EA, Lorenzo L. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol. 2009;27:182\u2013185.","journal-title":"Hematol Oncol."},{"key":"76_CR41","doi-asserted-by":"crossref","unstructured":"Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L. Commentary on the WHO classification of tumors of lymphoid tissues (2008): \u201cGray zone\u201d lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop. 2009:e-published.","DOI":"10.1007\/s12308-009-0039-7"},{"key":"76_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/10428199309148200","volume":"10","author":"A Karsan","year":"1993","unstructured":"Karsan A, Gascoyne RD, Coupland RW, Shepherd JD, Phillips GL, Horsman DE. Combination of t(14;18) and a Burkitt\u2019s type translocation in B-cell malignancies. Leuk Lymphoma. 1993;10:433\u2013441.","journal-title":"Leuk Lymphoma."},{"key":"76_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/modpathol.3800500","volume":"19","author":"A Kanungo","year":"2006","unstructured":"Kanungo A, Medeiros LJ, Abruzzo LV, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis. Mod Pathol. 2006;19:25\u201333.","journal-title":"Mod Pathol."},{"key":"76_CR44","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3324\/haematol.11263","volume":"92","author":"P Lin","year":"2007","unstructured":"Lin P, Medeiros LJ. High-grade B-cell lymphoma\/leukemia associated with t(14;18) and 8q24\/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis. Haematologica. 2007;92:1297\u20131301.","journal-title":"Haematologica."},{"key":"76_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","volume":"34","author":"M Snuderl","year":"2010","unstructured":"Snuderl M, Kolman OK, Chen YB, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34:327\u2013340.","journal-title":"Am J Surg Pathol."},{"key":"76_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1309\/AJCP7YLDTJPLCE5F","volume":"134","author":"D Wu","year":"2010","unstructured":"Wu D, Wood BL, Dorer R, Fromm JR. \u201cDouble-Hit\u201d mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression. Am J Clin Pathol. 2010;134:258\u2013265.","journal-title":"Am J Clin Pathol."},{"key":"76_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1309\/ELPKF130Q0MCMWU8","volume":"130","author":"CE Keller","year":"2008","unstructured":"Keller CE, Nandula S, Fisher J, et al. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations. Am J Clin Pathol. 2008;130:193\u2013201.","journal-title":"Am J Clin Pathol."},{"key":"76_CR48","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","volume":"24","author":"GW Imhoff van","year":"2006","unstructured":"van Imhoff GW, Boerma EJ, van der Holt B, et al. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:4135\u20134142.","journal-title":"J Clin Oncol."}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0076-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-010-0076-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0076-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-010-0076-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T13:44:57Z","timestamp":1637070297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-010-0076-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,31]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s11899-010-0076-4","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,31]]}}}